Natasha Kulviwat, a rising high school senior, discovered a protein that may serve as predictor for suicide and could potentially lead to new strategies for intervention and prevention.
In an accompanying editorial, Dr. Joshua T. Kantrowitz explained how the future role of lumateperone could be crucial in treating schizophrenia patients.
The Center for OCD and Related Disorders, directed by Dr. Blair Simpson, focuses on how to better understand, and ultimately treat, obsessive-compulsive disorder and related problems.
“The efficacy and safety profile of CAPLYTA approved by the FDA, offers healthcare providers an important new option for treating people living with schizophrenia,” said Dr. Jeffrey A. Lieberman.
"Considering the high risk of suicide after nonfatal opioid overdose, this information could be especially valuable in suicide prevention efforts," Dr. Mark Olfson said.
'It's likely that the increasing use of illicit fentanyl has contributed to the rapid increase in unintentional opioid overdose deaths,' explained Dr Mark Olfson.
Opioid-related suicides account for only 4% of opioid-related deaths, far below previous estimates of 20% to 30%, a new study from Columbia University has found.
Understanding differences in the brains of kids with familial risks may help identify those with highest odds for developing depression and could lead to improved treatment, said Dr. David Pagliaccio.
Dr. Elias Dakwar said he became interested in ketamine as a potential treatment for alcohol use disorder after seeing good results from using the drug to treat cocaine addiction.
A new study, led by researchers in the Department of Psychiatry at Columbia University, has revealed structural differences in the brains of those whose parents have depression.